One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes

A New Biology of Diabetes Revealed by Leptin

(2015) Roger H. Unger et al.   Cell Metabolism

Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin

(2015) Talia Diker-Cohen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Leptin Replacement Therapy on Pancreatic β-Cell Function in Patients With Lipodystrophy

(2014) Ranganath Muniyappa et al.   DIABETES CARE

What the Genetics of Lipodystrophy Can Teach Us About Insulin Resistance and Diabetes

(2013) Camille Vatier et al.   Current Diabetes Reports

Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety

(2011) Vinaya Simha et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of leptin and adiponectin on pancreatic β-cell function

(2011) Yong-ho Lee et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Efficacy of leptin therapy in the different forms of human lipodystrophy

(2009) A. Y. Chong et al.   DIABETOLOGIA

Making insulin-deficient type 1 diabetic rodents thrive without insulin

(2008) X. Yu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Leptin therapy for partial lipodystrophy linked to a PPAR-γ mutation

(2007) Jean-Marc Guettier et al.   CLINICAL ENDOCRINOLOGY